ResearcherGerman Cancer Research CenterNo recent work listed
Ivan Shevchenko
Matched on ORCID iD 0000-0002-6222-6553; OpenAlex author ID A5089304218. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2013: 1 paper · 2014: 1 paper · 2015: 1 paper
Papers 3
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells. Co-author DOI 10.1080/2162402x.2014.998519↗
- Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. First author DOI 10.1007/s00262-013-1485-8↗
- Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Co-author DOI 10.1002/ijc.27990↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Svetlana Karakhanova · 3 shared papers, 2013–2015 · strength 0.14
- Paper Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. DOI 10.1007/s00262-013-1485-8↗
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Jens Werner · 3 shared papers, 2013–2015 · strength 0.14
- Paper Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. DOI 10.1007/s00262-013-1485-8↗
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Alexandr V. Bazhin · 2 shared papers, 2013–2015 · strength 0.08
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Alexandr V. Bazhin · 1 shared paper, 2014 · strength 0.06
- Sabine Soltek · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.